Cuminaldehyde induces oxidative stress-mediated physical damage and death of Haemonchus contortus

Vanshita Goel1, Lachhman Das Singla2, Diptiman Choudhury1

  • 1School of Chemistry and Biochemistry, Thapar Institute of Engineering and Technology, Patiala, Punjab, 147004, India.

Insights

Cuminaldehyde (CA) effectively combats Haemonchus contortus by inducing oxidative damage and causing worm death. This natural compound shows greater preclinical potential than albendazole, offering new avenues for antihelminthic drug development.

Area of Science:

  • Parasitology
  • Natural Products Chemistry
  • Drug Discovery

Background:

  • Haemonchus contortus is a significant parasitic nematode affecting livestock.
  • Current anthelmintic drugs face challenges with resistance and toxicity.
  • Natural compounds offer potential alternatives for parasitic infection control.

Purpose of the Study:

  • To investigate the anthelmintic activity of Cuminaldehyde (CA) against Haemonchus contortus.
  • To compare the efficacy of CA with the standard drug albendazole.
  • To elucidate the mechanism of action of CA.

Main Methods:

  • Determination of lethal dose 50 (LD50) and half maximal inhibitory concentration (IC50) values for CA.
  • Scanning electron microscopy (SEM) to observe physical damage.
  • Measurement of reactive oxygen species (ROS) and antioxidant enzyme activities (CAT, SOD, GPx, GSH, NOS).

Main Results:

  • CA demonstrated significant toxicity to adult H. contortus and L3 larvae, with lower LD50 values than albendazole.
  • CA inhibited egg hatching effectively.
  • SEM revealed physical damage to worm structures upon CA exposure.
  • CA induced a systemic increase in ROS and modulated antioxidant enzyme activities, including significant increases in catalase, glutathione peroxidase, glutathione, and nitric oxide synthase.

Conclusions:

  • Cuminaldehyde exhibits potent in vitro anthelmintic activity against Haemonchus contortus.
  • CA's mechanism involves inducing oxidative stress and physical damage.
  • CA shows superior preclinical potential compared to albendazole, warranting further investigation as a novel antihelminthic agent.